Research shows significant regional differences in access to arthritis medications across Canada
The Conference Board of Canada released a report today, funded by the Arthritis Society, titled Accessing Arthritis Medications—A Pan-Canadian Analysis. The analyses presented in this report show that patients’ access to and the cost of arthritis medications differ by jurisdiction and type of drug plan.
The report findings support the Arthritis Society's call for urgent action on national pharmacare to address the needs of arthritis patients across Canada both now and in the future.
Back to News
Share